Introduction
Matrix metalloproteinases (MMPs) are a group of zinc enzymes which are capable of degrading components of extracellular matrix. Involvement of MMPs in physiological and pathological breakdown of connective tissue has been emphasized not only because they are secreted from the cells, and many of them have optimal enzymic activities around neutral pH, but also because the synthesis of most MMPs in connective tissue cells is regulated by monocyte-derived inflammatory mediators such as interleukin 1 or tumour necrosis factor, some growth factors, and several other agents (see [ 1, 21 for review). A number of members which belong to the MMP family have purified and characterized, and to date eight members have been identified on the basis of cDNA sequences.
All MMPs so far characterized share several common structural and biochemical properties. In this communication we describe substrate specificities of MMP-1 (tissue collagenase), MMP-2 ('72 kDa gelatinase/type IV collagenase'), MMP-3 (stromelysin), and MMP-9 ('92 kDa gelatinase/type IV collagenase') against various extracellular matrix components and the activation mechanisms of these enzymes from their precursors.
Protein substrate specificities of MMPs-I, -2, -3 and -9
MMPs-1, -2 and -3 were purified from the culture medium of rheumatoid synovial fibroblasts treated with the conditioned medium of rabbit macrophages [3-51, and MMP-9 from the culture medium of human fibrosarcoma cell line HT-1080 treated with phorbol myristate acetate. All enzymes were isolated as latent zymogen forms which were then activated under the optimal conditions [3-51, and examined for their abilities to digest various protein substrates (Table 1) . MMP-1 readily digests collagen type I, while other enzymes are unable to digest the helical region of this substrate. MMP-1 is also able to digest gelatin and reduced, carboxymethylated transferrin. Interestingly, gelatinolytic activity of MMP-1 is greater than that of MMP-3. Collagenolytic activity of MMP-1 was expressed when the enzyme was a 41 kDa species which contained both the catalytic and the C-terminal domains. Upon longer incubation of the 41 kDa MMP-1 at 37°C it underwent autolysis and 22 kDa and 27 kDa fragments were generated. The catalytic domain was identified in the 22 kDa fragment, which retained unchanged proteolytic activity against reduced, carboxymethylated transferrin but not the activity against collagen I. These observations indicate that the C-terminal domain is essential for MMP-1 to recognize collagen I as a substrate. Both the 41 kDa and the 22 kDa MMP-1 were inhibited by TIMP in a 1 : 1 molar stoichiometry. Similar autolysis occurred with MMP-3 upon activation and two species of MMP-3 (45 kDa and 28 kDa) were generated [6] . However, both species had indistinguishable substrate specificity and specific activity [3] , suggesting that the C-terminal domain of MMP-3 does not participate in expression of the enzyme specificity.
MMP-2 and MMP-9 are often referred to as gelatinases as they readily digest heat-denatured collagens (Table 1) . These enzymes have an extra domain before the zinc binding site in the catalytic domain, which consists of three repeats of 58 amino acid residues homologous to the gelatin binding domain of fibronectin [7] . This may explain why MMPs-2 and -9 have relatively high efficiencies to degrade gelatins. MMP-9 has an additional segment of 5 3 residues which has sequence similarity with the a2 chain of collagen V attached at the Cterminal side of the catalytic domain [8] , but the function of this sequence is not known. Although both MMP-2 and MMP-9 are also referred to as 'type IV collagenase', their activities against collagen IV is minimal. Both enzymes have much greater activities on collagen V. SDS/PAGE analysis of fragments of reduced, carboxymethylated transferrin generated by MMP-2 and MMP-9 indicated that MMP-2 degraded the substrate into small fragments, but only two major fragments were generated by MMP-9. Fibronectin was degraded by MMP-2 but it was relatively resistant to MMP-9. These observations suggest that MMP-2 and MMP-9 have different subsite requirements for their enzymic activities.
Activation mechanisms of MMPs
MMPs are secreted from the cells as inactive zymogens. T o understand the critical roles that MMPs play in connective tissue breakdown it is essential to learn the precise mechanisms of activation of these zymogens. W e have isolated proMMPs-1, -2, -3 and -9 and investigated their activation processes by various proteinases and 4-aminophenylmercuric acetate (APMA) in vitro.
Our studies have demonstrated that proMMP-1 and proMMP-3 are activated by the unique stepwise activation mechanisms through which sequential processing events occur in the propeptide region during activation [5, 91 . The initial cleavage sites attacked by activator proteinases are located in the middle of their propeptides and identified within the sequence of G1u"-LysArg-Arg-Asnj' in proMMP-1 and Phe"-Val-ArgArg-Lys-Asp3' in proMMP-3 (Fig. 1 ). Since these stretches of residues are highly charged, it is likely that they are exposed on the surface of the zymogen molecules and readily susceptible to proteolysis. The promiscuity of residues 34-39 in proMMP-3 allows activation of this zymogen to be triggered by a number of proteinases with different specificities, which include trypsin, tryptase, chymotrypsin, cathepsin G, plasmin, plasma kallikrein, neutrophil elastase, and thermolysin [6, 10, 111 . The initial attack of these proteinases on proMMP-3 (57 kDa) generated a 53 kDa intermediate which was then rapidly converted to a 45 kDa MMP-3 by specific hydrolysis of the Hisxz-Phex3 bond. The latter reaction was conducted by MMP-3, but not by the activator proteinase. The treatment of proMMP-3 with APMA resulted in the intramolecular cleavage of the Gluhx-Valh9 bond and generated a 46 kDa intermediate which was further converted to the 45 kDa MMP-3 by bimolecular reaction of the intermediates.
The initial cleavage of proMMP-1 was limited to proteinases which recognize Arg and/or Lys residues [5] . When proMMP-1 (52 kDa) was The final step involved in activation of proMMPs-1 and -3 requires the cleavage of the Glnx"-Phex' and the Hisx'-Phex3 bonds by MMP-3, respectively. These bonds, however, are not readily attacked by MMP-3 in a zymogen form. The initial removal of a portion of the propeptide from the Nterminus either by proteinase or in the presence of APMA results in conformational changes around the Glnx"-Phex' and the Hisx'-Phex3 bonds which render them susceptible to specific hydrolysis by MMP-3. The recent studies of proMMP-1 by Springman et al. [12] have suggested that the inactive zymogen of proMMP-1 is maintained by interaction of Cysi3 in the propeptide with the zinc atom in the catalytic site. Displacement of Cys'; from the zinc atom is considered to be a key event for expression of the catalytic function of MMP-1. This 'cysteine switch' mechanism is proposed to be applicable to all MMPs [ 131. Our studies have indicated that the removal of a portion of the propeptide from the N-teminus is sufficient for partial activation of proMMP-1 or proMMP-3, perhaps by destabilizing the Cys-zinc complex.
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A similar stepwise activation has been observed for proMMP-9 activation by MMP-3. In this case MMP-3 initially cleaved the Glu4'-Met4' bond, which then made the Argx7-Phexx bond susceptible to a second cleavage by MMP-3 (Fig. 1) .
A major difference found in the mode of activation of proMMP-2 compared with those of proMMPs-1, -3 and -9 is that proMMP-2 is not activated by any proteinases that we have examined so far [4] . This includes trypsin, chymotrypsin, plasmin, plasma kallikrein, chymase, thrombin, neutrophil elastase, cathepsin G, thermolysin and MMP-3. However, proMMP-2 was readily activated by APMA treatment and the AsnXo-TyrX' bond was cleaved during this treatment [4, 141 . The alignment of the propeptide regions of MMPs-1, -2 and -3
indicates that the sequence similarity in the proteinase susceptible region found in proMMPs-1 and -3 is not present in the corresponding region of proMMP-2 ( Fig. 1) . In addition, two cysteine residues are present in this region of proMMP-2. Thus, it is likely that proMMP-2 has a different secondary structure in this area of the propeptide. This may explain the insensitivity of proMMP-2 to the activation by many proteinases.
The stepwise activation mechanisms of proMMPs-1, -3 and -9 appear to be unique in this group of enzymes and they can be contrasted with activation mechanisms described for serine proteinases which require specific single cleavages [ 151.
We postulate that such activation systems may participate more precisely in regulation of catabolism of the connective tissue matrix. Availability of activator enzymes and the endogenous inhibitors of MMPs are clearly rate-limiting factors for the expression of MMP activities. When synthesis of MMPs is enhanced by stimulatory factors the production of TIMP is often elevated [16] [17] [18] . A higher level of a,-macroglobulin, a plasma proteinase inhibitor, has also been found in the inflamed lesions [19, 201. Thus, it is tempting to postulate that the stepwise activation systems may allow these endogenous inhibitors to interfere with activation processes of proMMPs. Interactions of MMP intermediates with these endogenous inhibitors are currently being investigated. We hope that such knowledge will allow us to gain more insight into the regulation of MMP zymogen activation in vivo and eventual control of connective tissue catabolism.
